Please provide your email address to receive an email when new articles are posted on . There are approximately 500 full-time fellowship-trained neuro- ophthalmologists in the U.S. to care for a ...

Mac McPherson once feared he’d never escape the spinning sensation that took over his life. But with expert care from U of U ...

Understanding the differences and similarities between neurological disorders and neurodegenerative diseases can be important when offering or accessing healthcare. It is also important for scientific ...

ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...

Join us for live demos, expert talks, and a ribbon-cutting as SAINT® TMS—an FDA-authorized 5-day treatment for depression—officially debuts on the East Coast. “Patients fly in from around the world ...

SOLANA BEACH, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the ...

Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in MDD subjects ATLANTA, March ...

Postnatal administration of corticosteroids for treatment and prevention of chronic lung disease such as bronchopulmonary dysplasia is a widespread practice and to date there have been no adequate ...

LOUISVILLE, Ky. (WDRB) -- A groundbreaking treatment for substance use disorder is changing lives by using neuro-stimulation, and it’s exclusively available in the Louisville area. For Teddy Edenstrom ...

The anticipated acquisition aligns with GE HealthCare’s precision care strategy with the goal of strengthening the company’s portfolio of offerings in neurological care and its quantitative analysis ...

ATLANTA, March 18, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of ...